These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68. Neuromodulation with levetiracetam and vagus nerve stimulation in experimental animal models of epilepsy. Dedeurwaerdere S; Vonck K; De Herdt V; Waterschoot L; De Smedt T; Raedt R; Wyckhuys T; Legros B; Van Hese P; Van Laere K; Delbeke J; Wadman W; Boon P Acta Neurol Belg; 2006 Jun; 106(2):91-7. PubMed ID: 16898260 [TBL] [Abstract][Full Text] [Related]
69. Lack of effects of vagus nerve stimulation on drug-resistant epilepsy in eight pediatric patients with autism spectrum disorders: a prospective 2-year follow-up study. Danielsson S; Viggedal G; Gillberg C; Olsson I Epilepsy Behav; 2008 Feb; 12(2):298-304. PubMed ID: 18053767 [TBL] [Abstract][Full Text] [Related]
70. Diffusion-weighted imaging and status epilepticus during vagus nerve stimulation. Tatum WO; Malek A; Recio M; Orlowski J; Murtagh R Epilepsy Behav; 2004 Jun; 5(3):411-5. PubMed ID: 15145313 [TBL] [Abstract][Full Text] [Related]
71. A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression. George MS; Rush AJ; Marangell LB; Sackeim HA; Brannan SK; Davis SM; Howland R; Kling MA; Moreno F; Rittberg B; Dunner D; Schwartz T; Carpenter L; Burke M; Ninan P; Goodnick P Biol Psychiatry; 2005 Sep; 58(5):364-73. PubMed ID: 16139582 [TBL] [Abstract][Full Text] [Related]
72. Vagal nerve stimulation: a review of its applications and potential mechanisms that mediate its clinical effects. Groves DA; Brown VJ Neurosci Biobehav Rev; 2005 May; 29(3):493-500. PubMed ID: 15820552 [TBL] [Abstract][Full Text] [Related]
73. Acute vagus nerve stimulation does not suppress spike and wave discharges in genetic absence epilepsy rats from Strasbourg. Dedeurwaerdere S; Vonck K; Claeys P; Van Hese P; D'Havé M; Grisar T; Naritoku D; Boon P Epilepsy Res; 2004; 59(2-3):191-8. PubMed ID: 15246120 [TBL] [Abstract][Full Text] [Related]
74. [Indications and results of nonpharmacological treatments of epilepsies: vagal stimulation, ketogenic diet and gamma rays]. Forcadas-Berdusán MI Rev Neurol; 2002 Sep; 35 Suppl 1():S144-50. PubMed ID: 12373666 [TBL] [Abstract][Full Text] [Related]
75. Vagus nerve stimulation (VNS) is effective in a rat model of antidepressant action. Krahl SE; Senanayake SS; Pekary AE; Sattin A J Psychiatr Res; 2004; 38(3):237-40. PubMed ID: 15003428 [TBL] [Abstract][Full Text] [Related]
76. Does vagal nerve stimulation affect body composition and metabolism? Experimental study of a new potential technique in bariatric surgery. Sobocki J; Fourtanier G; Estany J; Otal P Surgery; 2006 Feb; 139(2):209-16. PubMed ID: 16455330 [TBL] [Abstract][Full Text] [Related]
77. Annual variations of quantitative EEG in patients with chronic epilepsy. Sobaniec W; Kulak W; Bielewicz B; Sobaniec P Adv Med Sci; 2008; 53(2):321-5. PubMed ID: 19095583 [TBL] [Abstract][Full Text] [Related]
78. Vagus nerve stimulation for treatment of epilepsy in Rett syndrome. Wilfong AA; Schultz RJ Dev Med Child Neurol; 2006 Aug; 48(8):683-6. PubMed ID: 16836782 [TBL] [Abstract][Full Text] [Related]
79. [The effect of chronic Vagus Nerve Stimulation (VNS) on the central conduction time assessed by multimodal evoked potentials in patients with drug resistant epilepsy: preliminary report]. Rysz A; Koszewski W Neurol Neurochir Pol; 2003; 37(5):1113-25. PubMed ID: 15174257 [TBL] [Abstract][Full Text] [Related]
80. Analysis of RR variability in drug-resistant epilepsy patients chronically treated with vagus nerve stimulation. Galli R; Limbruno U; Pizzanelli C; Giorgi FS; Lutzemberger L; Strata G; Pataleo L; Mariani M; Iudice A; Murri L Auton Neurosci; 2003 Aug; 107(1):52-9. PubMed ID: 12927227 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]